Ignite Creation Date:
2024-05-06 @ 8:02 PM
Last Modification Date:
2024-10-26 @ 3:19 PM
Study NCT ID:
NCT06232434
Status:
NOT_YET_RECRUITING
Last Update Posted:
2024-04-22
First Post:
2024-01-08
Brief Title:
An Open Prospective Randomized Clinical Study of the Effectiveness Tolerability and Safety of a Single Intraperitoneal Use of the Drug Prospidelong Powder for the Preparation of a Gel for Topical Use 1000 mg in Vials Package No 1 in Patients With Disseminated Gastric Cancer Phase I-II
Sponsor:
Research Institute for Physical Chemical Problems of the Belarusian State University
Organization:
Research Institute for Physical Chemical Problems of the Belarusian State University
Key Dates - Follows AllAPIJSON File Order
Start Date:
2024-06
Start Date Type:
ESTIMATED
Primary Completion Date:
2024-12
Primary Completion Date Type:
ESTIMATED
Completion Date:
2024-12
Completion Date Type:
ESTIMATED
First Submit Date:
2024-01-08
First Submit QC Date:
January 22 2024
Study First Post Date:
2024-01-30
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-04-19
Last Update Post Date:
2024-04-22
Last Update Post Date Type:
ACTUAL